SCHEMBL4841552

SCHEMBL4841552

CC(C)(C)OC(=O)CCCOc1cccc(/C=C/N2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR2 Q9NS75 2/20 0.44
▸ CYSLTR1 Q9Y271 2/20 0.44
▸ AKR1B1 P15121 7/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ RAB9A P51151 2/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ TLR4 O00206 1/20 0.38
▸ TLR2 O60603 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ NR1H3 Q13133 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PTPN1 P18031 3/20 0.37
▸ PTPN2 P17706 2/20 0.37
▸ HDAC8 Q9BY41 1/20 0.36
▸ FAAH O00519 1/20 0.36
▸ PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841559 1.00 CYSLTR2 (0.44) CYSLTR2CYSLTR1AKR1B1L3MBTL1RAB9A
SCHEMBL4843078 0.95 L3MBTL1 (0.42) CYSLTR2CYSLTR1AKR1B1L3MBTL1RAB9A
SCHEMBL4843067 0.95 L3MBTL1 (0.42) CYSLTR2CYSLTR1AKR1B1L3MBTL1RAB9A
SCHEMBL4575361 0.79 FBP1 (0.44) L3MBTL1KMT2ANR1H3KDM4EALDH1A1
SCHEMBL4575360 0.79 FBP1 (0.44) L3MBTL1KMT2ANR1H3KDM4EALDH1A1
SCHEMBL6313868 0.79 MAOA (0.46) CYSLTR2CYSLTR1RAB9ATDP1TLR4
SCHEMBL4840291 0.77 RAB9A (0.50) L3MBTL1RAB9AKMT2ATDP1ALDH1A1
SCHEMBL29451792 0.76 HSD17B10 (0.41) RAB9AKMT2ATDP1NR1H3ALDH1A1
SCHEMBL6779922 0.75 PPARG (0.54) NR1H3
SCHEMBL6779926 0.75 PPARG (0.54) NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 — — US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 CYSLTR2 2201/4885CYSLTR1 1117/4885AKR1B1 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback